Will Krawszik

Will Krawszik is an experienced professional in the scientific and engineering sectors, currently serving as the Scientific Services Manager and Applications Scientist at Chemical Computing Group since May 2021. Will is the founder of Opportune Therapeutics, which has been operational since June 2018. Previously, Will co-founded and held the position of Operations Director at Moleculomics from December 2012 to June 2018, and worked as an Outreach Mentor at HPC Wales from September 2012 to May 2015. Will's academic background includes a PhD from Swansea University (2007-2009) and a BEng in Automotive Engineering from Oxford Brookes University (2000-2005). Early career experience includes roles as a Design Engineer at Trelleborg Offshore (2006-2007) and TVR Manufacturing Ltd (2003-2006), as well as serving as an Innovation Fellow at the University of Wales from February 2009 to August 2012.